X0306 4 2020-06-05 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001280044 GOWEN MAXINE C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET CAMBRIDGE MA 02142 true false false false Common Stock 2020-06-05 4 A false 13700.00 0.00 A 28700.00 D Common Stock 2020-06-08 4 S false 4567.00 12.05 D 24133.00 D Stock Option (Right to buy) 11.96 2020-06-05 4 A false 20100.00 0.00 A 2021-06-05 2030-06-05 Common Stock 20100.00 20100.00 D The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "RSUs"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 6, 2019. Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Stock Option"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer. /s/ Nicole R. Hadas, attorney-in-fact for Maxine Gowen 2020-06-09